ABSTRACT
INTRODUCTION
The polymerase chain reaction (PCR) amplifies DNA in vitro and requires primer annealing sites in each end of the target sequence (18) . Until recently, PCR required knowledge of the sequences initially flanking the target sequence. Therefore, PCR could not be used to amplify unknown DNA flanking a known sequence. Recently, several methods have been developed to overcome this limitation, and some have amplified >1.0 kb of genomic DNA flanking a known site (1,3,5-7, 9-11,13,15-17,19,20) . These methods allow one to walk into an uncharacterized region of DNA without screening a library of clones. Unlike previous methods, the method presented here amplifies >6.0 kb of DNA from bulk human genomic DNA with high specificity. It requires few oligonucleotides and steps.
Two methods previously developed in this laboratory are panhandle PCR and targeted inverted repeat amplification (5, 6) . These two methods and the variant presented here share creation of an inverted repeat through ligation of an oligonucleotide to a restriction endonuclease cut site in the unknown flanking DNA. The ligated oligonucleotide generates an inverted repeat because it is complementary to the known sequence, so that creation of the inverted repeat is restricted to the targeted strand. The two prior methods are designed so that intra-strand annealing of the ligated oligonucleotide to its complement in the known DNA can mediate template-directed extension of the ligated oligonucleotide's free end, using the known sequence as the template. In panhandle PCR, the ligated oligonucleotide has a free 3 ′ end, so intra-strand annealing can mediate template-directed extension of the ligated oligonucleotide using a DNA polymerase. In targeted inverted repeat amplification, the ligated oligonucleotide has a free and phosphorylated 5 ′ end, so that intra-strand annealing can mediate template-directed extension of this oligonucleotide through heat-stable ligation to an additional oligonucleotide. Template-directed extension of the ligated oligonucleotide appends known DNA to the unknown end in a strandspecific manner, so that the unknown DNA of interest is flanked by known DNA, allowing highly specific PCR amplification. The method presented in this paper is distinctive because it does not entail template-directed extension of the ligated oligonucleotide.
The method in this paper resembles targeted inverted repeat amplification because the ligated oligonucleotide has a free 5 ′ end. It differs from targeted, inverted repeat amplification because this oligonucleotide's 5 ′end is not phosphorylated, and there is no heatstable ligation step. This method differs from the original panhandle PCR method because an initial primer extension is required before a panhandle template is generated. The two protocols presented here do not require a glass-bead extraction step, and they use single oligonucleotides, further distinguishing this method from prior pan -handle PCR protocols. Use of XL PCR reagents (Roche Molecular Systems, Branchburg, NJ, USA) has allowed the amplification of >4.0 to 9.4 kb of DNA flanking the primer annealing sites in the original genomic DNA.
MATERIALS AND METHODS

Oligonucleotide Synthesis
Oligonucleotides were synthesized and HPLC-purified by Midland Certified Reagent (Midland, TX, USA). The oligonucleotide sequences and PCR primer melting temperature (T m ) are shown in Tables 1-3 . T m values were calculated using the computer program Oligo ™ Version 4.0 (National BioSciences, Plymouth, MN, USA) with its Analyze Menu under DNA Amplification.
Generation of a Template with a 5 ′ ′ End Extension Using a Restriction Endonuclease that Generates a 5 ′ ′ Overhang
Restriction enzyme digestion (Figure 1, Step 1) . Human genomic DNA (1.2 µ g) (Promega, Madison, WI, USA) was digested with 15 U Xba I, 12 USpe I, 15 U BamHI, 10 U Bgl II or 10 UBcl I (New England Biolabs, Beverly, MA, USA) in the manufacturer's corresponding 1 ×restriction endonuclease buffer in a total volume of 24 µ L at 37°C (50°C for Bcl I) for 2 h, generating a four-nucleotide-long 5 ′ overhang sequence. Four microliters were run on a minigel to assess completeness of digestion. Ten microliters were removed and added to 15.0 µ L of H 2 O, and the 25 µ L were saved for later use as a nonoligonucleotide-ligated control template.
Oligonucleotide ligation (Figure 1 manufacturer's 1 ×restriction endonuclease buffer and 1 × TdT buffer, in a total volume of 34 µ L at 37°C for 2 h. This generated a five-nucleotide-long 3 ′ overhang sequence and modified the template so that it could not undergo self-ligation. The mixture was incubated at 70°C for 10 min to heat-inactivate the TdT. In this experiment, the heatinactivation was also necessary to inactivate Sac I, because ligation of the oligonucleotide in Figure 2, Step 2 recreated the recognition domain for Sac I (see ligated oligonucleotide in Table 2 ). The concentration of ddCTP was very low (0.4 µ M) so that it would not interfere with the subsequent PCR amplifications. Ten microliters were removed and added to 15.0 µ L of H 2 O, and the 25 µ L were saved for later use as a non-oligonucleotide-ligated control template.
Oligonucleotide ligation (Figure 2, Step 2).
Ten microliters of the remaining cut genomic DNA were ligated to a 50-fold molar excess of an oligonucleotide (106 ng of 34-mer; its 3 ′ end is complementary to the AGCTCdd 3 ′ overhangs of the digested genomic DNA-see Table 2 ) in T 4 DNA Ligase buffer using one Weiss U T 4 DNA Ligase in a total volume of 24 µ L at 23°C for 2 h. Unligated oligonucleotides were eliminated by adding 1 µ L (20 U) of Exonuclease I (Epicentre Technologies) and incubating at 37°C for 30 min, followed by heat-inactivation at 75°C for 15 min (final concentration, 20 ng/ µ L of genomic DNA). . The template for the first tube was genomic DNA that had been restriction endonuclease-digested and had undergone oligonucleotide ligation; the template for the second tube was genomic DNA that had been restriction endonuclease-digested (control template that did not undergo ligation to the oligonucleotide); the template for the third tube was H 2 O (reagent control). All three tubes underwent thermal cycling as follows: 16 cycles of 93°C for 1 min followed by 68°C for 12 min. This was followed by 12 cycles of 93°C for 1 min, followed by 68°C for 12 min with a 15-s extension at 68°C per cycle. Then each tube was incubated at 72°C for 10 min, followed by a 4°C incubation. In one experiment, 1 µ L of the product of Step 3 was used as the template, and this template was placed above the wax bead (with 5.8 µ L H 2 O below the wax bead and 19.0 µ L H 2 O above the wax bead) and was re-amplified using Primer 1 to give the final product (see Results). Nested PCR using Primer 2 (Figure 1, Step 4) . This step is identical to the prior amplification (Step 3
Nested PCR using Primer 3 (Figure 1, Step 5 ). This step is identical to
Step 4, except that the product of Step 4 was used as the template, and Primer 3 was used instead of Primer 2.
Detection of PCR product. Nine microliters of each amplification product were analyzed by 1% agarose gel electrophoresis, followed by ethidium bromide staining.
Identifying PCR products. For the β -globin products, each Primer 3 PCR product (Step 5) was purified using an Amicon ® Centricon ® -100 Microconcentrator (Millipore, Bedford, MA, USA), and the unknown end of the DNA was directly sequenced using a sequencing primer containing the 17-20 nucleotides at the 3 ′ end of Primer 3 and an additional four 3 ′ nucleotides that anneal to the restriction endonuclease cut site (preventing priming off the known end). Cycle sequencing was done on a Model 373 Automated DNA Sequencer (PE Applied Biosystems, Foster City, CA, USA) using TaqDNA polymerase and labeled terminators (14) . The 4.5-and 4.8-kb cystic fibrosis transmembrane conductance regulator (CFTR) PCR products were cloned using recombination PCR (4), and their ends were sequenced as described previously (5). All products underwent restriction endonuclease fingerprinting to establish their identity. The unknown end of the 4.8-kb CFTR product was amplified directly from human genomic DNA using conventional PCR with one primer derived from the unknown end and the other derived from the known end. This amplified DNA was directly sequenced by cycle sequencing with labeled terminators (14 Bridging oligonucleotide used to juxtapose the 3 ′ end of Primer 3 to the 5 ′ end of Xba I-digested genomic DNA:
CTAGCAGGGCTGGGCATA (used to amplify 7.8-kb piece; annealing site to Xba I-cut genomic DNA underlined)
Oligonucleotide ligated to the 5 ′ end of Sac I-cut and ddCTP-extended (using TdT) DNA:
GCTCTGCCCTGACTTTTATGCCCAGCCCT GAGCT(used to amplify 9.5-kb piece; annealing site to genomic DNA's five-nucleotide-long 3 ′ overhang underlined)
PCR primers: 
RESULTS
General Strategy
The protocol illustrated in Figure 1 uses a restriction endonuclease that generates a 5 ′ overhang sequence, and the protocol illustrated in Figure 2 uses a restriction endonuclease that generates a 3 ′ overhang sequence. Using the protocol shown in Figure 2 , restriction endonuclease digestion of the genomic DNA is followed by addition of a single dideoxyribonucleotide using TdT. This prevents ligation of one substrate to another during oligonucleotide ligation, without preventing ligation to the single-stranded oligonucleotide. Following adaptor ligation, the 3 ′ -and single-strand-specific Exonuclease I eliminates free oligonucleotides in the protocol in Figure 2 and gives optimal results in the protocol in Figure 1 . In the protocol in Figure 1 , Primer 3, which is annealed to the bridging oligonucleotide, lacks a single-stranded 3 ′ end; but during incubation at 37°C, a temperature that lies near the equilibrium constant for the annealing 14-bp portion, dissociation from the bridging oligonucleotide allows digestion of unligated Primer 3. In each protocol, the ligated oligonucleotide is complementary to the known DNA, creating an inverted repeat that brackets the unknown flanking DNA of interest. Following oligonucleotide ligation, PCR amplification is carried out using a single primer (Primer 1). Primer 1 anneals immediately upstream to the complement of the ligated oligonucleotide, so that, during thermal cycling, template-directed DNA polymerization by Primer 1 generates a product whose 3 ′ end can anneal to its intra-strand complement. This intra-strand annealing generates a panhandle whose stem consists of two short annealing strands, one of which consists of the complement to the ligated oligonucleotide; and this strand has a recessed 3 ′ end that can undergo template-directed polymerization, generating a product that can undergo PCR amplification using Primer 1. This is followed by two nested, single-primer amplifications, using Primer 2 and then Primer 3 (the ligated oligonucleotide in its free form in Figure 1) . A variety of products have been amplified, as shown below.
Amplification of 6.7 kb of β β -Globin DNA Flanking Primer Annealing Sites in Human Genomic DNA
We amplified a 6829-bp β -globin DNA fragment containing 6737 bp flanking the primer annealing sites from Spe I-cut human genomic DNA. The targeted fragment was amplified with high specificity (Figure 3, lane 2) . Spe I was chosen because it was the farthest site that lies within the previously sequenced stretch of β -globin complex DNA (GenBank ® Accession No. J00179) that could be amplified using these oligonucleotides. The PCR product end flanking the Spe I cut site was directly sequenced, and the product underwent restriction endonuclease analysis, identifying the amplified sequence as the targeted β -globin sequence.
Amplification of 7.8 and 9.4 kb of β β -Globin DNA Flanking Primer Annealing Sites in Human Genomic DNA
In separate experiments, we amplified 7819-and 9490-bp fragments from the human β -globin DNA complex containing 7759 and 9430 bp DNA, respectively, flanking the primer annealing sites. The 7819-bp fragment was amplified using Xba I-cut genomic DNA (Figure 3, lane 5) , and the 9490-bp fragment was amplified using Sac Icut genomic DNA (Figure 3, lane 8) . The oligonucleotides (Table 2) were   136BioTechniques Vol. 23, No. 1 (1997) Figure 5 . Oligonucleotides used to amplify 7.8 kb of human genomic DNA from the β β -globin gene complex. The PCR primers are underlined. Primer 3 also functions as the ligated oligonucleotide and is redrawn as annealed to the bridging oligonucleotide. The bridging oligonucleotide is boxed. directed toward the opposite end of the β -globin complex when compared to the region amplified in lane 2 of Figure  3 . Each targeted product was obtained. The PCR product ends flanking their respective restriction endonuclease cut sites were directly sequenced, and each product underwent restriction endonuclease analysis, identifying each targeted product. The 9.4-kb product was also amplified with high specificity following two rounds of PCR amplification with Primer 1 only (56 total cycles; Figure 4 ). The annealing sites on the original template for the oligonucleotides used to amplify the 7.8-kb product are shown in Figure 5 . Previously, we attempted to amplify >4 kb of genomic DNA flanking the CFTR cDNA by using panhandle PCR and an oligonucleotide that had been ligated to genomic DNA that had been digested with Bcl I, Bgl II or BamHI. Only the Bcl I-cut genomic DNA generated a product, which was 4.5 kb (6) . Using the panhandle PCR variant presented here, we amplified a 4.5-kb piece using Bcl I-cut DNA ( Figure 6 , lane 2) and a 4.8-kb piece using Bgl IIcut DNA (Figure 6, lane 5) . A faint 7-kb piece was also amplified using BamHI-cut DNA ( Figure 6, lane 8) . The oligonucleotides are listed in Table  3 . Restriction endonuclease analysis revealed that the BamHI product was not derived from the region flanking the CFTR cDNA sequence, so that this faint product is a false-positive result. Sequencing and restriction endonuclease analysis of the cloned Bcl I and Bgl II products revealed that each was derived from the region lying upstream of the CFTR cDNA sequence. The Bgl II product included 249 bp of new sequence, which was also directly sequenced from human genomic DNA using conventional PCR (GenBank Accession No. U48778).
DISCUSSION
We present a genome walking protocol that has high specificity and few steps. This method uses ligation of an oligonucleotide to generate a 5 ′ end extension that creates a single-stranded inverted repeat, bracketing the unknown DNA of interest. The most likely way that a ligated oligonucleotide that generates a 5 ′ -end extension could create a PCR template for Primer 1 during thermal cycling is that the 3 ′ end of a completely extended Primer 1 product reanneals to its complementary sequence in the primer-extended strand, generating a panhandle template with a recessed 3 ′ end. This recessed 3 ′ end undergoes template-directed polymerization during a panhandle PCR, generating a PCR template that can be amplified by Primer 1. PCR amplification of the product of interest can occur with high specificity using a single primer (Primer 1). Consistent high specificity and product yield has required one or two subsequent single-primer nested PCR amplifications, and we routinely use two subsequent PCR amplifications (using Primer 2 and then Primer 3). If we used Primer 1 for 50 cycles, followed by Primer 3 for 28 cycles (no amplification with Primer 2), the product was obtained with high specificity in each of these experiments, except for the Spe I experiment amplifying β -globin DNA (not shown). The best results were obtained when Exonuclease I was used and when terminal transferase was used in the protocol illustrated in Figure 2, but neither step was essential in a three-primer protocol (not shown).
The protocols presented use single primers to amplify unknown flanking DNA. We have found previously that long inverted repeat ends impede PCR amplification (6) and have found that single primers amplify long products with greater specificity than two primers (not shown). This results from the ability of single-primer amplification to suppress the amplification of short products. Caetano-Anolles et al. described the primer-template interactions that occur during DNA amplification with single primers and noted that the primer must compete for annealing with the hairpin loops formed by the terminal palindromes of single strands (2) . K.B. Mullis first described inhibition of the amplification of a short PCR product by a single primer by noting that formation of the primer-dimer artifact requires two primers (12) . More recently, Lukyanov et al. have used varying concentrations of a single primer to modulate the length of amplified cDNA products (8) . We have found that single primers suppress the amplification of short products under routine PCR amplification conditions, with little effect on the relative amplification efficiency of products >1 kb (unpublished data).
The method presented here is a variant of panhandle PCR that retains the best aspects of targeted, inverted repeat amplification and the original panhandle PCR method. It uses single primers like targeted, inverted repeat amplification, but avoids the heat-stable ligation step, does not require a phosphorylated oligonucleotide and works at least as well. The method presented here requires fewer primers than the original panhandle PCR method, and its initial panhandle template has a shorter inverted repeat. Furthermore, use of single primers gave higher specificity with this method than the use of two primers during each PCR amplification as was done in the original panhandle PCR method.
The variant of panhandle PCR presented here has several applications, including chromosome walking, retrieval of unclonable genomic DNA, determination of viral and transposon integration sites, retrieval of chromosomal breakage and integration sites and the amplification of fragments adjacent to cDNA including regulatory regions. It is easy to carry out and specific for the product of interest.
